Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Soleno Therapeutics (SLNO) EPS (Basic) (2016 - 2025)

Soleno Therapeutics (SLNO) has disclosed EPS (Basic) for 9 consecutive years, with $0.85 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) changed N/A to $0.85 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.3 through Dec 2025, changed N/A year-over-year, with the annual reading at $0.4 for FY2025, 109.13% up from the prior year.
  • EPS (Basic) for Q4 2025 was $0.85 at Soleno Therapeutics, up from $0.49 in the prior quarter.
  • The five-year high for EPS (Basic) was $0.85 in Q4 2025, with the low at -$0.95 in Q1 2025.